Reset Your Metabolism. Reclaim Your Form.
Dual-action GLP-1/GIP receptor protocol. The most advanced single-agent weight management medication available.
⚠ Prescription required · Labs required · Ships 3–7 business days
Tirzepatide is a dual-action GLP-1/GIP receptor agonist — the most advanced single-agent weight management medication available. While semaglutide activates one receptor (GLP-1), tirzepatide simultaneously activates two: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism produces the most powerful and sustained metabolic effect of any single medication in this class.
The GLP-1 pathway reduces appetite and slows gastric emptying. The GIP pathway adds enhanced insulin sensitivity, improved lipid metabolism, and additional appetite suppression through a separate hormonal pathway. Together, they produce results that consistently exceed single-receptor agents in clinical trials.
Like semaglutide, tirzepatide is administered as a once-weekly subcutaneous injection with a structured titration schedule. Your provider starts at 2.5mg weekly and adjusts upward based on your response, lab results, and tolerability.
Tirzepatide is recommended when significant weight management is the goal — typically 30 pounds or more — or when single-receptor GLP-1 agents haven’t produced sufficient results. The dual-receptor mechanism produces superior outcomes, particularly for abdominal fat and insulin resistance.
GLP-1 and GIP pathways work synergistically — producing metabolic outcomes that single-receptor agents cannot match.
Clinical trials demonstrated an average of 20–22% body weight reduction over 72 weeks with the highest dose tier.
The GIP pathway provides additional metabolic support beyond appetite reduction, particularly beneficial for patients with insulin resistance.
Same convenience as semaglutide. Sterile needles and alcohol swabs included with every shipment.
Your provider selects the appropriate tier based on your body composition, metabolic profile, and goals.
Structured dose escalation from 2.5mg to 15mg over months, optimizing results while minimizing side effects.
Tirzepatide is available in Standard and Advanced dosing tiers, each with 30-day and 90-day supply options.
Standard dosing tier for initial titration and patients on lower-to-mid dose ranges.
Advanced dosing tier for patients on higher dose ranges or with greater weight management goals.
If your weight management goal is significant — 30 pounds or more — tirzepatide’s dual-receptor mechanism delivers the strongest single-agent results available.
If a single-receptor GLP-1 produced some results but you’ve hit a plateau, the addition of the GIP pathway can restart progress.
The GIP receptor pathway provides enhanced insulin sensitization beyond what GLP-1-only agents deliver.
Tirzepatide is the most advanced commercially available GLP-1 agent. For patients committed to comprehensive metabolic optimization, it’s the strongest tool available.
Your Biology. Reborn.
Medical Disclaimer: The information on this page is for educational purposes and does not constitute medical advice. All BioPhoenix protocols require a provider evaluation and prescription. Individual results vary based on health history, lab values, and adherence to the prescribed protocol.
Compounding Disclosure: Compounded medications are prepared by a licensed 503A compounding pharmacy. Compounded medications are not FDA-approved but are prepared in compliance with federal and state pharmacy regulations. All compounds are sterile, third-party tested, and dispensed pursuant to a valid prescription.
Pricing Disclosure: Prices shown are medication costs. Total program pricing includes provider evaluation, clinical oversight, and shipping. See program page for complete pricing details.
BioPhoenix Inc. is a Management Services Organization (MSO). BioPhoenix does not practice medicine. All clinical decisions are made by independent licensed providers. BioPhoenix supports, optimizes, and enhances access to care — it does not diagnose, treat, cure, or prevent any disease.
BioPhoenix Inc. is a marketing and management services organization. We are not a medical practice, pharmacy, or licensed healthcare provider. All clinical services are provided by independent, licensed healthcare professionals operating through licensed physician-owned professional corporations. All medical consultations are performed exclusively by licensed medical providers. Prescriptions are issued at the sole discretion of treating physicians and are not guaranteed. Medications are dispensed by licensed compounding pharmacies. BioPhoenix services are not available to individuals under 18 years of age. These services are not a substitute for emergency care. If you are experiencing a medical emergency, call 911 immediately.BioPhoenix is not a covered entity under HIPAA. Your health information is handled pursuant to our Privacy Policy and Business Associate Agreements with our clinical partners.
